Comparing surgical and non-surgical treatment for rib fractures
Official title: Prospective Multi-center Comparative Study of RibFix Blu Thoracic Fixation System Versus Non-surgical Treatment in Non-flail Chest Rib Fractures
Run by Zimmer Biomet · NCT05146986 · Data updated 2026-11-12
This study is testing whether a new surgical method for fixing rib fractures works better than regular pain management for people with non-flail chest rib fractures.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 167 (estimated) |
| Sponsor | Zimmer Biomet Industry-sponsored |
| Locations | 5 sites (Sydney, New South Wales and 4 other locations) |
| Status | Recruiting |
| Started | January 2, 2022 |
| Main results expected | December 30, 2025 |
| Study ends | December 30, 2026 |
| Registry record updated | March 7, 2024 |
| Trial ID | NCT05146986 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with simple rib fractures involving three or more consecutive ribs that are displaced.
✕Probably not a fit
Patients with flail chest rib fractures or those with serious medical conditions that prevent them from tolerating surgery will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study aims to evaluate the effectiveness of the RibFix Blu Thoracic Fixation System for surgical stabilization of non-flail chest rib fractures compared to non-surgical treatment methods such as analgesia and symptomatic management. Conducted across multiple centers, the study will enroll up to 167 patients, with a competitive recruitment process among sites. The goal is to assess outcomes from both treatment approaches, providing insights into the benefits of surgical intervention for this specific type of rib fracture.
Why it matters
Potential benefit: If successful, this study could provide evidence supporting surgical treatment as a more effective option for patients with non-flail chest rib fractures.
How similar studies have gone: While there is existing literature on surgical stabilization of rib fractures, this specific approach using the RibFix Blu system is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 and above (inclusive) * Simple rib fracture with ≥ 3 consecutive ribs, and the broken ends showed clear displacements * Indicated for surgical repair of rib fractures using RibFix Blu Thoracic Fixation System or non-surgical treatment (analgesia and symptomatic management treatment) * Willing and able to complete scheduled follow-up evaluations as described in the study protocol * Has participated in the Informed Consent process and is willing and able to sign an Institutional Review Board or Ethics Committee (IRB/EC) approved Patient Information/ Informed consent Form (PICF) Exclusion Criteria: * Flail chest rib fractures based on radiological or clinical findings * Previous rib fractures or pulmonary problems, requiring continuous oxygen use at home pre-trauma * Presence of any serious medical issues that placed patient in generally poor conditions such that he or she could not tolerate the surgery * Chest trauma associated with severe craniocerebral injury, abdominal organ injury, severe spinal injury, limb fracture, or pelvic fracture requiring long-term bed rest * Has serious medical disease that is a contraindication for general anesthesia, such as cerebral infarction, myocardial infarction and hemorrhagic syndrome * Any contraindications listed in the manufacturer's Instruction to use for RibFix Blu Thoracic Fixation System as per below: * Spanning a midline sternotomy * Active Infection * Foreign body sensitivity * Is known to be pregnant * Is a prisoner, known alcohol or drug user or mentally incompetent or unable to understand what participation in this study entails. * Participation in another surgical intervention that may influence any of the outcome parameters.
Where it's running
-
Flinders Medical Centre
Bedford Park, South Australia, Australia Recruiting -
The Alfred (Alfred Health)
Melbourne, Victoria, Australia Recruiting -
Yonsei Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, South Korea Recruiting -
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea Recruiting -
Hunter New England Health District
Sydney, New South Wales, Australia Not yet recruiting
Study contacts
- Principal investigator: Silvana Marasco, Professor — The Alfred
- Study coordinator: Irene Chong
- Email: irene.chong@zimmerbiomet.com
- Phone: 97566687
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if a new tomosynthesis imaging tool helps diagnose MSK issues in ED and clinic
This study tests whether the Nanox.ARC Digital Tomosynthesis system can add diagnostic value for adults with suspected MSK problems and potentially reduce the need for CT or MRI.
-
REMS testing for osteoporosis diagnosis and fracture risk in adults compared with DXA
This study tests whether REMS can diagnose osteoporosis and predict fracture risk in adults who are being evaluated for bone health, using DXA as the standard reference.
-
See how well iFuse TORQ TNT works for pelvic fragility fractures
This study tests the iFuse TORQ TNT implant in older adults with pelvic fragility fractures to see if real-world use leads to better outcomes.
-
Buprenorphine for pain relief in older adults with broken bones in the ED
This study tests whether buprenorphine can safely and effectively relieve pain in older adults with acute fractures, compared with hydromorphone.
-
Cannabidiol for pain relief after traumatic fractures and to reduce opioid use
We will test whether taking cannabidiol twice daily for one month can reduce pain and opioid use in adults 18–70 treated for recent long-bone fractures at Sacré-Coeur Hospital.
-
Observing outcomes of the Medacta Shoulder System
This study is looking at how well the Medacta Shoulder System works and its safety for people with different shoulder problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.